Technical Analysis for KLTO - Klotho Neurosciences, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.42 | -14.47% | -0.07 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
New 52 Week Closing Low | Bearish | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Reached Oversold | Weakness | -14.47% | |
Wide Bands | Range Expansion | -14.47% | |
Down 3 Days in a Row | Weakness | -14.47% |
Alert | Time |
---|---|
Possible NR7 | about 22 hours ago |
60 Minute Opening Range Breakdown | about 23 hours ago |
Down 5% | 1 day ago |
Down 3% | 1 day ago |
Down 2 % | 1 day ago |
Get a Trading Assistant
- Earnings date: Unknown
Klotho Neurosciences, Inc. Description
Klotho Neurosciences, Inc. formerly ANEW MEDICAL, INC., is a Nasdaq-listed pharmaceutical company with the ticker symbol KLTO. The company specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders. The Company obtained exclusive worldwide rights to platform technologies and knowhow to develop cutting edge protein, gene and cell therapies to treat age-related pathologies such as ALS, Alzheimer’s and Parkinson’s disease, multiple sclerosis, and rare neurodegenerative diseases. The company is managed by a team of individuals and advisors that are highly experienced in medical product development and commercialization of medical products.
Classification
Sector: Financial Services
Industry: Shell Companies
Keywords: Pharmaceutical Multiple Sclerosis Platform Technologies Parkinson’s Disease
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 13.1 |
52 Week Low | 0.3901 |
Average Volume | 607,854 |
200-Day Moving Average | 5.33 |
50-Day Moving Average | 0.72 |
20-Day Moving Average | 0.55 |
10-Day Moving Average | 0.55 |
Average True Range | 0.10 |
RSI (14) | 35.06 |
ADX | 18.74 |
+DI | 17.88 |
-DI | 25.08 |
Chandelier Exit (Long, 3 ATRs) | 0.57 |
Chandelier Exit (Short, 3 ATRs) | 0.70 |
Upper Bollinger Bands | 0.71 |
Lower Bollinger Band | 0.38 |
Percent B (%b) | 0.11 |
BandWidth | 60.26 |
MACD Line | -0.07 |
MACD Signal Line | -0.07 |
MACD Histogram | 0.0 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.60 | ||||
Resistance 3 (R3) | 0.61 | 0.56 | 0.57 | ||
Resistance 2 (R2) | 0.56 | 0.51 | 0.55 | 0.56 | |
Resistance 1 (R1) | 0.49 | 0.49 | 0.46 | 0.48 | 0.55 |
Pivot Point | 0.44 | 0.44 | 0.43 | 0.43 | 0.44 |
Support 1 (S1) | 0.37 | 0.39 | 0.34 | 0.36 | 0.29 |
Support 2 (S2) | 0.32 | 0.37 | 0.31 | 0.28 | |
Support 3 (S3) | 0.25 | 0.32 | 0.27 | ||
Support 4 (S4) | 0.24 |